The delta-globin RNA transcript level in beta-thalassemia carriers

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Background:

• Beta-thalassemia carriers typically exhibit elevated hemoglobin A2 (HbA2) levels.
• The underlying molecular mechanisms for increased HbA2 in carriers remain unclear.
• Potential causes include transcriptional and posttranscriptional regulatory changes.

Purpose of the Study:

• To quantify delta-globin mRNA levels in peripheral blood reticulocytes of beta-thalassemia heterozygotes.
• To investigate the correlation between delta-globin mRNA levels and specific Chinese beta-thalassemia alleles.
• To explore the relationship between delta-globin mRNA, red blood cell indices, and HbA2 levels.

Main Methods:

• Development of a sensitive quantitative competitive reverse-transcriptase polymerase chain reaction (RT-PCR) assay.
• Measurement of absolute delta-mRNA transcript amounts in peripheral erythroid cells.
• Analysis of 30 beta-thalassemia heterozygotes with common Chinese beta-thalassemia alleles and 12 controls.

Main Results:

• Significantly elevated delta-mRNA levels were observed in all beta-thalassemia carriers compared to controls (72.3 amol/µg RNA vs. 1.2 amol/µg RNA).
• Delta-mRNA levels showed a direct correlation with the type of beta-thalassemia allele, being higher in beta(0)-thalassemia mutations than beta(+)-thalassemia mutations.
• Inverse correlation between delta-mRNA levels and hemoglobin/red cell indices, and a direct correlation with HbA2 levels.

Conclusions:

• Increased delta-globin gene transcription contributes to elevated HbA2 levels in beta-thalassemia carriers.
• The degree of beta-globin gene expression impairment correlates with delta-globin gene transcription and subsequent HbA2 levels.
• These findings elucidate a key mechanism behind HbA2 elevation in beta-thalassemia heterozygotes.